Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of lutropin alfa added to controlled ovarian stimulation in women of advanced reproductive age
2008-002281-55Phase 2Completed
- Sponsor
- Merck Santé
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of lutropin alfa in female infertility (2 arms), sponsored by Merck Santé. Primary endpoint: Implantation rate. Started Jul 2008; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2008-002281-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002281-55.